Eva Dombi
0000-0002-5323-6995
National Cancer Institute
21 papers found
Refreshing results…
The MEK inhibitor selumetinib reduces spinal neurofibroma burden in patients with NF1 and plexiform neurofibromas
Missing publications? Search for publications with a matching author name.